|View printer-friendly version|
|Cynosure Acquires Assets of RF Medical Device Manufacturer Ellman International, Inc.|
"This transaction complements our brand portfolio, expands our market opportunities and enhances our recurring revenue stream," said Cynosure Chairman and Chief Executive Officer
Ellman's product line encompasses multiple RF generators and single-use electrodes for aesthetic and multi-specialty surgical indications such as facial plastic and general surgery, gynecology, ear, nose and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. Ellman's proprietary high frequency, low-temperature RF technology is optimized for achieving surgical precision and controlled hemostasis.
"The efficacy of products such as Ellman's versatile Surgitron® radiowave platform technology is supported by clinical validation in more than 300 surgical publications," Davin said. "What differentiates Ellman's platform technology is its ability to consistently achieve favorable clinical outcomes with minimal tissue damage, rapid recovery and less scarring."
In addition to Surgitron, the Ellman product line includes the RF-based Pelleve® Wrinkle Reduction System. Pelleve is a skin tightening system for non-ablative skin rejuvenation that can be performed in an hour or less, is pain free and is associated with no downtime for the patient. In
"The cost-effective Pelleve and PelleFirm systems provide an attractive entry point for medispas and non-core physicians seeking to build their aesthetic practices," Davin said. "For patients, these non-invasive treatments deliver quickly visible results with no pain or downtime, thereby allowing for an immediate return to normal activity."
Ellman has approximately 100 employees, including an 18-person direct sales force in
Acquisition Conference Call